Exagen Inc. (XGN)

Exagen Revenue

Exagen had revenue of $55.73M in the twelve months ending March 31, 2024, with 20.12% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $14.42M with 28.36% year-over-year growth. In the year 2023, Exagen had annual revenue of $52.55M with 15.33% growth.

• Revenue (ttm): $55.73M
• Revenue Growth: +20.12%
• P/S Ratio: 0.61
• Revenue / Employee: $311,358
• Employees: 179
• Market Cap: 34.05M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	52.55M	6.99M	15.33%
Dec 31, 2022	45.56M	-2.74M	-5.66%
Dec 31, 2021	48.30M	6.32M	15.07%
Dec 31, 2020	41.98M	1.59M	3.93%
Dec 31, 2019	40.39M	7.95M	24.50%
Dec 31, 2018	32.44M	5.63M	21.01%
Dec 31, 2017	26.81M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.